TAPI and Antheia have announced a new strategic partnership designed to support the commercialization of Antheia’s biosynthetic key starting materials (KSMs) and active pharmaceutical ingredients (APIs). Antheia will leverage TAPI’s next-generation fermentation capabilities and manufacturing facilities in Europe to scale its pipeline and accelerate time to market for future product launches. This collaboration combines Antheia’s […]
Transforming GLP-1 Manufacturing with PAT-Generated Data: A Smarter, Greener Approach
Sustainable by Design: How TAPI is Building a Greener Future in API Manufacturing
How Innovative Computational Tools and Automation Are Reshaping Solid Form Development
Driving Innovation in Green Chemistry: Redox Biocatalysis Allowing Full Stereocontrol
Driving Bioprocess Innovation: How TAPI Is Transforming Fermentation Efficiency with Smart Automation
Strengthening Process Safety: Inside TAPI’s New HAZOP Training Program
Advancing Crystallization Process Development with In-line PAT Tools
TAPI’s Scientific Publication Showcases Breakthrough in Enzymatic Synthesis
Teva API had a successful inspection in the Teva api Mexico site by Local MOH
Teva API had a successful inspection in the Teva api India, Gajraula site by Local MOH
Teva API had a successful inspection in the Teva api Croatia, Zagred site by Local MOH